- Home
- TCRX vs NAUT Comparison
TCRX vs NAUT Comparison
Compare TCRX & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- NAUT
- Stock Information
- Founded
- TCRX 2018
- NAUT 2016
- Country
- TCRX United States
- NAUT United States
- Employees
- TCRX N/A
- NAUT N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- TCRX Health Care
- NAUT Industrials
- Exchange
- TCRX Nasdaq
- NAUT Nasdaq
- Market Cap
- TCRX 82.1M
- NAUT 91.5M
- IPO Year
- TCRX 2021
- NAUT N/A
- Fundamental
- Price
- TCRX $1.45
- NAUT $0.69
- Analyst Decision
- TCRX Strong Buy
- NAUT Hold
- Analyst Count
- TCRX 6
- NAUT 2
- Target Price
- TCRX $9.50
- NAUT $3.88
- AVG Volume (30 Days)
- TCRX 669.3K
- NAUT 553.0K
- Earning Date
- TCRX 08-11-2025
- NAUT 07-29-2025
- Dividend Yield
- TCRX N/A
- NAUT N/A
- EPS Growth
- TCRX N/A
- NAUT N/A
- EPS
- TCRX N/A
- NAUT N/A
- Revenue
- TCRX $4,421,000.00
- NAUT N/A
- Revenue This Year
- TCRX $159.20
- NAUT N/A
- Revenue Next Year
- TCRX N/A
- NAUT N/A
- P/E Ratio
- TCRX N/A
- NAUT N/A
- Revenue Growth
- TCRX N/A
- NAUT N/A
- 52 Week Low
- TCRX $1.02
- NAUT $0.66
- 52 Week High
- TCRX $7.89
- NAUT $3.09
- Technical
- Relative Strength Index (RSI)
- TCRX 46.44
- NAUT 43.84
- Support Level
- TCRX $1.39
- NAUT $0.69
- Resistance Level
- TCRX $1.73
- NAUT $0.85
- Average True Range (ATR)
- TCRX 0.15
- NAUT 0.06
- MACD
- TCRX -0.02
- NAUT 0.00
- Stochastic Oscillator
- TCRX 12.53
- NAUT 8.70
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.